Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC.

被引：0

作者：

Lee, Jiyun

Cho, Jaeho

Lee, Chang

Lee, Chang Young

Lee, Jin Gu

Kim, Dae Joon

Shim, Hyo Sup

Lim, Sun Min

Kim, Hye Ryun

Cho, Byoung Chul

Hong, Min Hee

机构：

[1] Yonsei Univ, Lung Canc Ctr, Yonsei Canc Ctr, Coll Med, Seoul, South Korea

[2] Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea

[3] Yonsei Univ, Heavy Ion Res Inst, Yonsei Canc Ctr, Coll Med,Dept Radiat Oncol, Seoul, South Korea

[4] Yonsei Univ, Severance Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea

[5] Yonsei Univ, Dept Pathol, Severance Hosp, Coll Med, Seoul, South Korea

[6] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea

[7] Yonsei Univ, Severance Hosp, Div Med Oncol,Coll Med, Dept Internal Med,Yonsei Canc Ctr, Seoul, South Korea

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8556

引用

页数：1